Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
95.62m
Last Price
$2.97
52-Week Range
$2.07 - $4.20
03/28/2025 08:00 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808